Search Within

Daphna Y Gelblum

  1. "Neuroradiology Service"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
Groups
  1. Department of Medicine (10)
  2. Head and Neck Service (10)
  3. Neuroradiology Service (10)
  4. Radiation Oncology, Department of (10)
  5. Radiology, Department of (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Eric Sherman (10)
  2. Nancy Lee (10)
  3. David Pfister (8)
  4. Jay Boyle (7)
  5. Nadeem Riaz (7)
  6. Richard Wong (7)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2021 (1)
  4. 2017 (2)
  5. 2016 (1)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. International Journal of Radiation Oncology, Biology, Physics (3)
  3. Annals of Oncology (1)
  4. Head & Neck (1)
  5. International Journal of Particle Therapy (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (3)
  3. John Wiley & Sons, Inc. (1)
  4. Oxford University Press (1)
  5. Particle Therapy Cooperative Group (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early disease recurrence following post-operative HPV ctDNA directed active surveillance in oropharyngeal carcinoma – Outcomes of a prospective pilot study
    Meeting Abstract

    Chen, L.; Cohen, M.; Hatzoglou, V.; Zhang, Z.; Riaz, N.; Wong, R. J.; McBride, S.; Gelblum, D.; Boyle, J. O.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A pilot study evaluating selective minimal residual disease directed adjuvant radiation in human papilloma virus associated oropharynx carcinoma
    Meeting Abstract

    Chen, L.; Cohen, M.; Hatzoglou, V.; Zhang, Z.; Ganly, I.; Boyle, J. O.; Singh, B.; Morris, L. G.; Wong, R. J.; Cracchiolo, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schöder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base
    Journal Article

    Kitpanit, S.; Lee, A.; Pitter, K. L.; Fan, D.; Chow, J. C. H.; Neal, B.; Han, Z.; Fox, P.; Sine, K.; Mah, D.; more...
    International Journal of Particle Therapy (2021)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation therapy dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers treated with concurrent chemoradiation therapy
    Meeting Abstract

    Riaz, N.; Sherman, E.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J. O.; Singh, B.; Morris, L.; Wong, R. J.; Tsai, C. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
    Journal Article

    Fury, M. G.; Xiao, H.; Sherman, E. J.; Baxi, S.; Smith-Marrone, S.; Schupak, K.; Gewanter, R.; Gelblum, D.; Haque, S.; Schoder, H.; more...
    Head & Neck (2016)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save